EXTENT OF SHOCK-INDUCED MEMBRANE LEAKAGE IN HUMAN AND MOUSE MYOTUBES DEPENDS ON DYSTROPHIN

MENKE A, Jockusch H (1995)
JOURNAL OF CELL SCIENCE 108: 727-733.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
Abstract / Bemerkung
A lack of the cytoskeletal protein dystrophin causes muscle fiber necrosis in Duchenne/Becker muscular dystrophies (DMD/BMD) and in murine X-linked muscular dystrophy (MDX). However, no overt disease symptoms are observed in dystrophin-less cultured myotubes, and the biological function of dystrophin in normal muscle cells is still unknown. In this work, we have extended our studies on a model system, using hypoosmotic shock to determine stress resistance of muscle cells. In frozen sections of control human and mouse myotubes, dystrophin was shown to be localized at the cell periphery as in mature muscle fibers. Dystrophin-less DMD and MDX myotubes were more susceptible to hypoosmotic shock than controls, as monitored by the uptake of external horseradish peroxidase and release of the soluble enzymes creatine kinase or pyruvate kinase and of radiolabelled proteins. Control experiments indicated that this difference is not due to differences in metabolism or ion fluxes. Treatment with cytochalasin D drastically increased the shock sensitivity of myotubes and abolished the difference between dystrophin-less and control cells. These results lend further support to the suggested stabilizing role of dystrophin in the context of the membrane-cytoskeletal complex.
Erscheinungsjahr
Zeitschriftentitel
JOURNAL OF CELL SCIENCE
Band
108
Seite(n)
727-733
ISSN
PUB-ID

Zitieren

MENKE A, Jockusch H. EXTENT OF SHOCK-INDUCED MEMBRANE LEAKAGE IN HUMAN AND MOUSE MYOTUBES DEPENDS ON DYSTROPHIN. JOURNAL OF CELL SCIENCE. 1995;108:727-733.
MENKE, A., & Jockusch, H. (1995). EXTENT OF SHOCK-INDUCED MEMBRANE LEAKAGE IN HUMAN AND MOUSE MYOTUBES DEPENDS ON DYSTROPHIN. JOURNAL OF CELL SCIENCE, 108, 727-733.
MENKE, A., and Jockusch, H. (1995). EXTENT OF SHOCK-INDUCED MEMBRANE LEAKAGE IN HUMAN AND MOUSE MYOTUBES DEPENDS ON DYSTROPHIN. JOURNAL OF CELL SCIENCE 108, 727-733.
MENKE, A., & Jockusch, H., 1995. EXTENT OF SHOCK-INDUCED MEMBRANE LEAKAGE IN HUMAN AND MOUSE MYOTUBES DEPENDS ON DYSTROPHIN. JOURNAL OF CELL SCIENCE, 108, p 727-733.
A. MENKE and H. Jockusch, “EXTENT OF SHOCK-INDUCED MEMBRANE LEAKAGE IN HUMAN AND MOUSE MYOTUBES DEPENDS ON DYSTROPHIN”, JOURNAL OF CELL SCIENCE, vol. 108, 1995, pp. 727-733.
MENKE, A., Jockusch, H.: EXTENT OF SHOCK-INDUCED MEMBRANE LEAKAGE IN HUMAN AND MOUSE MYOTUBES DEPENDS ON DYSTROPHIN. JOURNAL OF CELL SCIENCE. 108, 727-733 (1995).
MENKE, A, and Jockusch, Harald. “EXTENT OF SHOCK-INDUCED MEMBRANE LEAKAGE IN HUMAN AND MOUSE MYOTUBES DEPENDS ON DYSTROPHIN”. JOURNAL OF CELL SCIENCE 108 (1995): 727-733.

48 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
Capogrosso RF, Mantuano P, Uaesoontrachoon K, Cozzoli A, Giustino A, Dow T, Srinivassane S, Filipovic M, Bell C, Vandermeulen J, Massari AM, De Bellis M, Conte E, Pierno S, Camerino GM, Liantonio A, Nagaraju K, De Luca A., FASEB J 32(2), 2018
PMID: 29097503
Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D.
Carotti M, Marsolier J, Soardi M, Bianchini E, Gomiero C, Fecchio C, Henriques SF, Betto R, Sacchetto R, Richard I, Sandonà D., Hum Mol Genet 27(6), 2018
PMID: 29351619
PEO-PPO Diblock Copolymers Protect Myoblasts from Hypo-Osmotic Stress In Vitro Dependent on Copolymer Size, Composition, and Architecture.
Kim M, Haman KJ, Houang EM, Zhang W, Yannopoulos D, Metzger JM, Bates FS, Hackel BJ., Biomacromolecules 18(7), 2017
PMID: 28535058
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
Young CS, Hicks MR, Ermolova NV, Nakano H, Jan M, Younesi S, Karumbayaram S, Kumagai-Cresse C, Wang D, Zack JA, Kohn DB, Nakano A, Nelson SF, Miceli MC, Spencer MJ, Pyle AD., Cell Stem Cell 18(4), 2016
PMID: 26877224
Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid.
Shimizu-Motohashi Y, Asakura Y, Motohashi N, Belur NR, Baumrucker MG, Asakura A., PLoS One 10(3), 2015
PMID: 25775477
Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo.
Houang EM, Haman KJ, Filareto A, Perlingeiro RC, Bates FS, Lowe DA, Metzger JM., Mol Ther Methods Clin Dev 2(), 2015
PMID: 26623440
Elusive sources of variability of dystrophin rescue by exon skipping.
Vila MC, Klimek MB, Novak JS, Rayavarapu S, Uaesoontrachoon K, Boehler JF, Fiorillo AA, Hogarth MW, Zhang A, Shaughnessy C, Gordish-Dressman H, Burki U, Straub V, Lu QL, Partridge TA, Brown KJ, Hathout Y, van den Anker J, Hoffman EP, Nagaraju K., Skelet Muscle 5(), 2015
PMID: 26634117
Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.
Uaesoontrachoon K, Quinn JL, Tatem KS, Van Der Meulen JH, Yu Q, Phadke A, Miller BK, Gordish-Dressman H, Ongini E, Miglietta D, Nagaraju K., Hum Mol Genet 23(12), 2014
PMID: 24463621
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies.
Ayoglu B, Chaouch A, Lochmüller H, Politano L, Bertini E, Spitali P, Hiller M, Niks EH, Gualandi F, Pontén F, Bushby K, Aartsma-Rus A, Schwartz E, Le Priol Y, Straub V, Uhlén M, Cirak S, 't Hoen PA, Muntoni F, Ferlini A, Schwenk JM, Nilsson P, Al-Khalili Szigyarto C., EMBO Mol Med 6(7), 2014
PMID: 24920607
Acute blood flow restricted exercise to treat Duchenne muscular dystrophy: would it be efficacious?
Loenneke JP, Thiebaud RS, Abe T, Manfro IG, Marin PJ., Front Physiol 4(), 2013
PMID: 23720637
Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.
Verhaert D, Richards K, Rafael-Fortney JA, Raman SV., Circ Cardiovasc Imaging 4(1), 2011
PMID: 21245364
Exercise and Duchenne muscular dystrophy: toward evidence-based exercise prescription.
Markert CD, Ambrosio F, Call JA, Grange RW., Muscle Nerve 43(4), 2011
PMID: 21404285
Mapping of the lipid-binding and stability properties of the central rod domain of human dystrophin.
Legardinier S, Raguénès-Nicol C, Tascon C, Rocher C, Hardy S, Hubert JF, Le Rumeur E., J Mol Biol 389(3), 2009
PMID: 19379759
New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD.
Constantin B, Sebille S, Cognard C., J Muscle Res Cell Motil 27(5-7), 2006
PMID: 16897576
Imaging and elasticity measurements of the sarcolemma of fully differentiated skeletal muscle fibres.
Defranchi E, Bonaccurso E, Tedesco M, Canato M, Pavan E, Raiteri R, Reggiani C., Microsc Res Tech 67(1), 2005
PMID: 16025488
Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice.
Friedrich O, Both M, Gillis JM, Chamberlain JS, Fink RH., J Physiol 555(pt 1), 2004
PMID: 14594987
Inspiratory loading does not accelerate dystrophy in mdx mouse diaphragm: implications for regenerative therapy.
Krupnick AS, Zhu J, Nguyen T, Kreisel D, Balsara KR, Lankford EB, Clark CC, Levine S, Stedman HH, Shrager JB., J Appl Physiol (1985) 94(2), 2003
PMID: 12531909
Function and genetics of dystrophin and dystrophin-related proteins in muscle.
Blake DJ, Weir A, Newey SE, Davies KE., Physiol Rev 82(2), 2002
PMID: 11917091
Hypotonic medium increases calcium permeant channels activity in human normal and dystrophic myotubes.
Vandebrouck C, Duport G, Raymond G, Cognard C., Neurosci Lett 323(3), 2002
PMID: 11959428
Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.
Ruegg UT, Nicolas-Métral V, Challet C, Bernard-Hélary K, Dorchies OM, Wagner S, Buetler TM., Neuromuscul Disord 12 Suppl 1(), 2002
PMID: 12206810
Cationic channels in normal and dystrophic human myotubes.
Vandebrouck C, Duport G, Cognard C, Raymond G., Neuromuscul Disord 11(1), 2001
PMID: 11166168
Variations in dystrophin complex in red and white caudal muscles from Torpedo marmorata.
Royuela M, Hugon G, Rivier F, Fehrentz JA, Martinez J, Paniagua R, Mornet D., J Histochem Cytochem 49(7), 2001
PMID: 11410610
Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease.
Berchtold MW, Brinkmeier H, Müntener M., Physiol Rev 80(3), 2000
PMID: 10893434
Muscle degeneration without mechanical injury in sarcoglycan deficiency.
Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, McNally EM., Proc Natl Acad Sci U S A 96(19), 1999
PMID: 10485893
Dystrophin binding to nonmuscle actin.
Renley BA, Rybakova IN, Amann KJ, Ervasti JM., Cell Motil Cytoskeleton 41(3), 1998
PMID: 9829780
Caveolin-3 is not an integral component of the dystrophin glycoprotein complex.
Crosbie RH, Yamada H, Venzke DP, Lisanti MP, Campbell KP., FEBS Lett 427(2), 1998
PMID: 9607328
Brain biochemistry in Duchenne muscular dystrophy: a 1H magnetic resonance and neuropsychological study.
Rae C, Scott RB, Thompson CH, Dixon RM, Dumughn I, Kemp GJ, Male A, Pike M, Styles P, Radda GK., J Neurol Sci 160(2), 1998
PMID: 9849797
Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state.
Disatnik MH, Dhawan J, Yu Y, Beal MF, Whirl MM, Franco AA, Rando TA., J Neurol Sci 161(1), 1998
PMID: 9879685
Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
Krämer R, Lochmüller H, Abicht A, Rüdel R, Brinkmeier H., Neuromuscul Disord 8(8), 1998
PMID: 10093060
Mutual interference of myotonia and muscular dystrophy in the mouse: a study on ADR-MDX double mutants.
Heimann P, Augustin M, Wieneke S, Heising S, Jockusch H., Neuromuscul Disord 8(8), 1998
PMID: 10093061
Impaired functional and structural recovery after muscle injury in dystrophic mdx mice.
Irintchev A, Zweyer M, Wernig A., Neuromuscul Disord 7(2), 1997
PMID: 9131653
Loss, restoration, and maintenance of plasma membrane integrity.
McNeil PL, Steinhardt RA., J Cell Biol 137(1), 1997
PMID: 9105031
Deletion in the Z-line region of the titin gene in a baby hamster kidney cell line, BHK-21-Bi.
Jäckel M, Witt C, Antonova O, Curdt I, Labeit S, Jockusch H., FEBS Lett 408(1), 1997
PMID: 9180260
Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.
Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR., Cell 90(4), 1997
PMID: 9288752
Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro.
Imbert N, Vandebrouck C, Constantin B, Duport G, Guillou C, Cognard C, Raymond G., Neuromuscul Disord 6(5), 1996
PMID: 8938699
[Molecular pathogenesis of muscular diseases].
Ohlendieck K., Naturwissenschaften 83(12), 1996
PMID: 9036337
Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro.
Imbert N, Cognard C, Duport G, Guillou C, Raymond G., Cell Calcium 18(3), 1995
PMID: 8529258

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 7769014
PubMed | Europe PMC

Suchen in

Google Scholar